Evidence map›Paper›PMID 36759972›Full record

ArticleCancer2023

Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18-26 and 27-45 years in the United States: A cross-sectional study.

Mariana Arevalo, Naomi C Brownstein, Junmin Whiting, Susan T Vadaparampil, Katharine J Head, Cathy D Meade, Jessica Y Islam, Monica L Kasting, Clement K Gwede, Veronica Barrios-Monroy and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Primary Care Providers' Perspectives on Barriers and Facilitators to Human Papillomavirus (HPV) Vaccination among Young Adults: A Qualitative Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mariana ArevaloDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-5825-532X
Naomi C BrownsteinDepartment of Public Health Services, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-9991-427X
Junmin WhitingDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0003-1515-5200
Susan T VadaparampilDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0002-1052-6917
Katharine J HeadDepartment of Communication Studies, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.ORCID 0000-0001-8946-1716
Cathy D MeadeDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-6422-8248
Jessica Y IslamDepartment of Oncological Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.ORCID 0000-0002-3690-3848
Monica L KastingDepartment of Public Health, College of Health and Human Sciences, Purdue University, West Lafayette, Indiana, USA.ORCID 0000-0002-9879-7235
Clement K GwedeDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0003-1630-7333
Veronica Barrios-MonroyNTRO Non-Therapeutic Research Office, Moffitt Cancer Center, Tampa, Florida, USA.
Shannon M ChristyDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-5306-7020
University of South Florida · USMoffitt Cancer Center · USMedical University of South Carolina · USPurdue University West Lafayette · USUniversity of Indianapolis · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Translating Measures of Visual Experience to Children with Autism and Down SyndromeKL2TR002530 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI ROBB, SHERI L · 2018 to 2022
$4.8M
NCATS NIH HHS KL2 TR002530NCATS NIH HHS KL2TR002530 (Tucker Edmonds)NCATS NIH HHS UL1 TR001450NCATS NIH HHS UL1 TR002529NCATS NIH HHS UL1TR002529 (Moe & Wiehe)NCI NIH HHS P30 CA076292NCI NIH HHS P30-CA076292
6 · The paper itself

Abstract

backgroundThe current study examined self-reported human papillomavirus (HPV) vaccination uptake and intentions, and associations with psychosocial constructs among United States adults aged 18 to 26 and 27 to 45 years.

methodsData were collected via an online survey from participants recruited from a research panel. Outcomes were HPV vaccination uptake and intentions. Multivariable binary and ordered logistic regression models were used to examine associations between HPV vaccination outcomes and psychosocial constructs, sociodemographics, and previous health behaviors.

resultsHPV vaccination uptake in both age cohorts (N =  2722) was associated with multiple variables, including but not limited to: provider recommendation (adjusted odds ratio [aOR], 11.63 [95% CI, 7.70-17.56] and aOR, 14.26 [95% CI, 9.52-21.38], for those aged 18 to 26 and 27 to 45 years, respectively) and positive HPV vaccine attitudes (aOR, 2.40 [95% CI, 1.70-3.40] and aOR, 1.46 [95% CI,1.06-2.02]). Among those who did not report or were unsure of prior HPV vaccination (N =1894), only 4.6% and 8.1% (aged 18-26 and 27-45 years, respectively) reported being very likely to receive the HPV vaccine in the next year. Increased intentions were associated with more positive vaccine attitudes (aOR, 2.45 [95% CI, 1.91-3.15] and aOR, 2.19 [95% CI, 1.72-2.78]) and provider recommendation (yes vs no; aOR, 1.97 [95% CI, 1.38-2.83] and aOR, 1.82 [95% CI, 1.31-2.52]; don't know/can't remember vs no; aOR, 1.38 [95% CI, 1.03-1.84] and aOR, 1.60 [95% CI, 1.17-2.18]). Sociodemographics and health behaviors associated with increased intentions differed for each age cohort.

conclusionsIndividual and interpersonal factors were associated with HPV vaccination uptake and intentions. Findings reveal the need for targeted interventions to improve HPV vaccination rates among these age groups.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdultCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeHuman Papillomavirus VirusesHumansIntentionPatient Acceptance of Health CareSurveys and QuestionnairesUnited StatesVaccinationPapillomavirus Vaccinesadultscancer preventionHPV vaccinehuman papillomavirusintentionsvaccination

Identifiers

PMID36759972
PMCPMC10470643
OpenAlexW4319814194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.